Abbisko Cayman Limited (2256.HK)

HKD 7.83

(-6.23%)

Total Liabilities Summary of Abbisko Cayman Limited

  • Abbisko Cayman Limited's latest annual total liabilities in 2023 was 134.28 Million CNY , down -6.2% from previous year.
  • Abbisko Cayman Limited's latest quarterly total liabilities in 2024 Q1 was 120.16 Million CNY , down -10.51% from previous quarter.
  • Abbisko Cayman Limited reported annual total liabilities of 143.16 Million CNY in 2022, up 20.83% from previous year.
  • Abbisko Cayman Limited reported annual total liabilities of 118.48 Million CNY in 2021, down -93.31% from previous year.
  • Abbisko Cayman Limited reported quarterly total liabilities of 120.16 Million CNY for 2024 Q1, down -10.51% from previous quarter.
  • Abbisko Cayman Limited reported quarterly total liabilities of 134.28 Million CNY for 2023 FY, down -6.2% from previous quarter.

Annual Total Liabilities Chart of Abbisko Cayman Limited (2023 - 2019)

Historical Annual Total Liabilities of Abbisko Cayman Limited (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 134.28 Million CNY -6.2%
2022 143.16 Million CNY 20.83%
2021 118.48 Million CNY -93.31%
2020 1.77 Billion CNY 127.26%
2019 779.26 Million CNY 0.0%

Peer Total Liabilities Comparison of Abbisko Cayman Limited

Name Total Liabilities Total Liabilities Difference
Uni-Bio Science Group Limited 152.81 Million HKD 12.131%
CK Life Sciences Int'l., (Holdings) Inc. 7.05 Billion HKD 98.098%